Western Pennsylvania Hospital Hematology & Cellular Therapy — Pittsburgh, Pennsylvania

Western Pennsylvania Hospital Hematology & Cellular Therapy is a clinical research site located in Pittsburgh, Pennsylvania, United States 15524.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

Western Pennsylvania Hospital Hematology & Cellular Therapy has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Relapsed/Refractory Follicular Lymphoma, Follicular Lymphoma, Refractory Follicular Lymphoma.

Sponsors: Epizyme, Inc..

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Western Pennsylvania Hospital Hematology & Cellular Therapy?

Western Pennsylvania Hospital Hematology & Cellular Therapy has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Western Pennsylvania Hospital Hematology & Cellular Therapy conducted?

Western Pennsylvania Hospital Hematology & Cellular Therapy has 1 clinical trials on record, with 1 currently active. Their work covers Relapsed/Refractory Follicular Lymphoma, Follicular Lymphoma, Refractory Follicular Lymphoma.

Is Western Pennsylvania Hospital Hematology & Cellular Therapy accredited by Crixeo Health?

Western Pennsylvania Hospital Hematology & Cellular Therapy has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Western Pennsylvania Hospital Hematology & Cellular Therapy?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.